Page last updated: 2024-09-04

perifosine and Genital Neoplasms, Female

perifosine has been researched along with Genital Neoplasms, Female in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, D; Aoki, Y; Hasegawa, K; Kagabu, M; Kamiura, S; Kimura, T; Mabuchi, S; Mizuno, M; Ochiai, K; Oda, K; Okamoto, A; Saito, T; Takehara, K; Yamaguchi, S; Yunokawa, M1

Trials

1 trial(s) available for perifosine and Genital Neoplasms, Female

ArticleYear
Phase II basket trial of perifosine monotherapy for recurrent gynecologic cancer with or without PIK3CA mutations.
    Investigational new drugs, 2017, Volume: 35, Issue:6

    Topics: Adult; Aged; Class I Phosphatidylinositol 3-Kinases; Cohort Studies; Female; Follow-Up Studies; Genital Neoplasms, Female; Humans; Middle Aged; Mutation; Neoplasm Recurrence, Local; Phosphorylcholine; Prognosis

2017